Harris Hydraulics Building
1705 NE Pacific St.
MD (Harvard University)
MPH (Johns Hopkins University)
BA (Princeton University)
Impact of HIV and other STDs on women and adolescents; STD/HIV interactions; HIV vaccine clinical trials; implementation science and program management
Judith N. Wasserheit is a Professor of Medicine and Global Health and Vice Chair of the Department of Global Health. She is also an Affiliate Investigator the Fred Hutchinson Cancer Research Center. She was formerly the Director of the HIV Vaccine Trials Network, a global clinical trials platform linking 28 sites on four continents in evaluating preventive HIV vaccines; led the CDC's national STD prevention program for almost a decade; and was the founding chief of the NIH's STD research branch. She has had extensive experience in sexually transmitted disease (STD) and HIV research, policy development, and program implementation both in the United States and in developing countries.
Current research interests include: mathematical modeling of the combined effects of biological co-factors such as HSV-2 infection, malaria, and TB on HIV epidemic trajectory; examining the impact of HSV-2 infection and other STDs on response to HIV vaccine candidates; designing and evaluating combination HIV prevention packages for sub-Saharan Africa; developing and evaluating multi-component interventions to reduce STDs, HIV, and pregnancy among adolescents, and developing and evaluating approaches to adaptation to climate change to reduce the impact on human health.
Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012 Feb 9;366(6):485-7. PMID:22316442.
Moreno MA, Brockman LN, Wasserheit JN, Christakis DA. A pilot evaluation of older adolescents' sexual reference displays on Facebook. J Sex Res. 2012;49(4):390-9. Epub 2012 Jan 12. PMID:22239559.
Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L; NIAID HIV Vaccine Trials Network. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):238-44. PMID:21860356.
Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS. 2011 Aug 24;25(13):1559-73. Review. PMID:21633287.
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2011 Mar;8(1):62-72. Review. PMID:20941553.
Wetmore CM, Manhart LE, Wasserheit JN. Randomized Controlled Trials of Interventions to Prevent Sexually Transmitted Infections: Learning From the Past to Plan for the Future. Epidemiol Rev. 2010 Apr;32(1):121-36. Epub 2010 Jun 2. Review. PMID:20519264.
Padian, Nancy S., McCoy, Sandra I., Balkus, Jennifer, Wasserheit, Judith N. Challenges in HIV Prevention Research: Weighing the Gold in the Gold Standard. AIDS 2010;24(9):621-635. PMID:20179575.
Barnabas RV, Wasserheit JN. Riddle of the Sphinx Revisited: The Role of STDs in HIV Prevention. Sexually Transmitted Diseases 2009; 36(6):365-367. PMID:19434009.
Golden MR, Wasserheit JN. Prevention of Viral Sexually Transmitted Infections—Foreskin at the Forefront. New England Journal of Medicine [Editorial], 2009:360;13:1349-1351. PMID:19321872.
Koplan JP, Bond TC, Merson M, Wasserheit JN. Towards a Common Definition of Global Health. Lancet 2009;373:1993-95. PMID:19493564.